1/5/2023 8:04:46 AM
Biogen Names Priya Singhal As EVP, Head Of Development
1/4/2023 7:41:52 AM
Biogen, Alcyone Therapeutics Enter License Agreement To Develop Alcyone's ThecaFlex DRx System
12/19/2022 7:48:27 AM
Biogen Agrees With Genentech To Get Royalties On Commercialization For Glofitamab
12/9/2022 7:36:27 AM
Biogen Says FDA Accepts For Review The Abbreviated BLA For BIIB800
12/5/2022 7:38:02 AM
Biogen: EMA Accepts Tofersen Marketing Authorization Application To Treat Rare, Genetic Form Of ALS
11/29/2022 7:54:39 PM
Eisai Presents Full Results Of Lecanemab Phase 3 Confirmatory Clarity Ad Study For Early Alzheimer's Disease